Tumor Constraints | |||||||
---|---|---|---|---|---|---|---|
Conformal Pelvic Vessel Targeting | |||||||
Structure | Importance | Max Dose (Gy) | Max Dose Penalty | DVH Volume (%) | DVH Dose (Gy) | Minimum Dose (Gy) | Minimum Dose Penalty |
PTV1 | 10 | 68 | 10 | 95 | 68 | 68 | 33 |
Rt Iliac Nodal Volume | 10 | 68 | 1 | 95 | 45 | 45 | 10 |
Lt Iliac Nodal Volume | 10 | 68 | 1 | 95 | 45 | 45 | 10 |
PTV1 = prostate + 7.5 mm | |||||||
Conformal Normal Tissue Avoidance | |||||||
Structure | Importance | Max Dose (Gy) | Max Dose Penalty | DVH Volume (%) | DVH Dose (Gy) | Minimum Dose (Gy) | Minimum Dose Penalty |
PTV1 | 10 | 68 | 10 | 95 | 68 | 68 | 33 |
PTVcnta | 10 | 68 | 10 | 95 | 45 | 45 | 10 |
PTVcnta = PTV1 + lymph node planning target volume + pelvic soft tissue target | |||||||
Sensitive Structure Constraints | |||||||
Structure | Importance | Max Dose (Gy) | Max Dose Penalty | DVH Volume (%) | DVH Dose (Gy) | DVH Penalty | Â |
Rectum | 1 | 68 | 1 | 40 | 30 | 1 | Â |
Bladder | 1 | 68 | 1 | 40 | 30 | 1 | Â |
Lt Femur | 1 | 45 | 1 | 50 | 20 | 1 | Â |
Rt Femur | 1 | 45 | 1 | 50 | 20 | 1 | Â |
Small Bowel | 1 | 40 | 1 | 1 | 38 | 1 | Â |
Field Width = 5.0 cm Pitch = 0.286 Planning Modulation Factor = 4.0 |